Oberweis Asset Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16M Sell
621,759
-1,328
-0.2% -$35K 0.36% 102
2026
Q2
$15.8M Sell
623,087
-78,000
-11% -$1.77M 0.33% 107
2026
Q1
$15M Buy
701,087
+141,100
+25% +$2.94M 0.44% 91
2025
Q4
$12M Buy
559,987
+14,387
+3% +$295K 0.44% 92
2025
Q3
$9.14M Hold
545,600
– – 0.35% 107
2025
Q2
$7.83M Hold
545,600
– – 0.34% 105
2025
Q1
$7.91M Buy
545,600
+79,000
+17% +$1.12M 0.39% 92
2024
Q4
$6.12M Buy
+466,600
New +$6.44M 0.29% 126
2020
Q1
– Sell
-30,811
Closed -$856K – 190
2019
Q4
$856K Sell
30,811
-2,800
-8% -$70.2K 0.29% 90
2019
Q3
$760K Buy
33,611
+8,746
+35% +$199K 0.17% 100
2019
Q2
$627K Buy
24,865
+8,400
+51% +$226K 0.11% 121
2019
Q1
$447K Buy
16,465
+8,765
+114% +$294K 0.09% 147
2018
Q4
$254K Buy
7,700
+1,100
+17% +$44.2K 0.06% 176
2018
Q3
$308K Buy
+6,600
New +$303K 0.06% 184

Other funds holding MD

Oberweis Asset Management's MD Position: Q3 2026 in Review

Oberweis Asset Management reduced its Pediatrix Medical (MD) stake by 0.21% in Q3 2026, selling an estimated $35K and leaving 621,759 shares worth $16M. The position accounts for 0.36% of the portfolio, ranked #102.

Oberweis Asset Management first reported a position in MD in Q3 2018 and has held it in 14 quarters since. 313 funds tracked by Wall St. Rank hold MD as of Q3 2026.

  • Oberweis Asset Management held 621,759 shares of Pediatrix Medical worth $16M as of Q3 2026.
  • Oberweis Asset Management sold 1,328 Pediatrix Medical shares in Q3 2026, an estimated $35K.
  • Pediatrix Medical made up 0.36% of Oberweis Asset Management's portfolio in Q3 2026, its #102 holding.
  • Oberweis Asset Management first reported a position in Pediatrix Medical in Q3 2018 and has held it in 14 quarters since.
  • 313 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2026.

Based on Oberweis Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.